Industry
Real Estate - Services
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Loading...
Open
1.80
Mkt cap
45M
Volume
16K
High
1.91
P/E Ratio
-1.30
52-wk high
2.50
Low
1.80
Div yield
N/A
52-wk low
1.29
Portfolio Pulse from Benzinga Newsdesk
December 14, 2023 | 9:05 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2023 | 8:40 pm
Portfolio Pulse from Happy Mohamed
August 15, 2023 | 12:19 pm
Portfolio Pulse from Benzinga Newsdesk
June 13, 2023 | 8:06 pm
Portfolio Pulse from Benzinga Newsdesk
June 05, 2023 | 12:06 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.